2025
Preconception and Prenatal Environment and Growth Faltering Among Children in Uganda
Ssentongo P, Fronterre C, Ericson J, Wang M, Al-Shaar L, Greatrex H, Omadi P, Muvawala J, Greybush S, Mbabazi P, Murray-Kolb L, Muwanguzi A, Schiff S. Preconception and Prenatal Environment and Growth Faltering Among Children in Uganda. JAMA Network Open 2025, 8: e251122. PMID: 40105840, PMCID: PMC11923699, DOI: 10.1001/jamanetworkopen.2025.1122.Peer-Reviewed Original ResearchConceptsWeight-for-height z-scoreHeight-for-age z-scoreWeight-for-age z-scoreIndividuals aged 0Z-scoreAged 0Distribution of undernutritionAssociated with height-for-age z-scoresGrowth falteringPublic health programsAssociated with weight-for-age Z-scoreCross-sectional studyHeight-for-ageWeight-for-heightChild growth outcomesWeight-for-ageCost-effective deliveryHealth SurveyHealth programsMain OutcomesAnthropometric measurementsUgandan DemographicGrowth outcomesChildhood growth outcomesSpatial scales
2022
Evidence-based Discharge Nutrition to Optimize Preterm Infant Outcomes.
Taylor SN, Martin CR. Evidence-based Discharge Nutrition to Optimize Preterm Infant Outcomes. NeoReviews 2022, 23: e108-e116. PMID: 35102382, DOI: 10.1542/neo.23-2-e108.Peer-Reviewed Original ResearchConceptsOral feeding abilityOral feeding skillsPreterm infantsMaternal milkPreterm infants' oral feeding skillsInfants' oral feeding skillsPreterm infant outcomesTerm infant formulaIdeal clinical approachHospital dischargeNeurodevelopmental outcomesInfant outcomesHospital dietFeeding skillsClinical approachInfant formulaInfantsGrowth outcomesEquivocal resultsDietOutcomesNutrient densitySufficient nutritionIntakeNutrition
2020
Animal Source Food Intake and Growth Outcomes in Children Aged 6–59 Months: An Ecological Analysis from the Global Dietary Database
Miller V, Webb P, Cudhea F, Zhang J, Shi P, Reedy J, Puklin L, Coates J, Micha R, Mozaffarian D. Animal Source Food Intake and Growth Outcomes in Children Aged 6–59 Months: An Ecological Analysis from the Global Dietary Database. Current Developments In Nutrition 2020, 4: nzaa061_081. PMCID: PMC7258874, DOI: 10.1093/cdn/nzaa061_081.Peer-Reviewed Original ResearchDisability-adjusted life yearsUnder-5 MortalityGlobal Dietary DatabaseChildren Aged 6Animal source foodsAnimal source food intakeAged 6Associated with disability-adjusted life yearsDietary databaseGlobal Burden of Disease StudyBurden of Disease StudyAssociated with underweightSex-specific strataCross-sectional associationsPoisson regression modelsP-value <Cross-sectional natureEstimated mean intakeUnder-5Intake dataGrowth outcomesGlobal burdenMean intakeIntake of animal source foodsOverweight/obesityUrinary trace metals in association with fetal ultrasound measures during pregnancy
Kim S, Meeker J, Aung M, Yu Y, Mukherjee B, Cantonwine D, McElrath T, Ferguson K. Urinary trace metals in association with fetal ultrasound measures during pregnancy. Environmental Epidemiology 2020, 4: e075. PMID: 32201854, PMCID: PMC7083213, DOI: 10.1097/ee9.0000000000000075.Peer-Reviewed Original ResearchEstimated Fetal WeightBirth weightFetal weightZ-scoreAssociated with higher birth weightHead circumference z-scoreAssociated with low birth weightMeasures of fetal growthFetal ultrasound measurementsLength z-scoreLow birth weightHigh birth weightMeasured abdominal circumferenceGestational ageFetal growthAbdominal circumferenceHead circumferenceInterquartile range increaseEssential metalsLIFECODES birth cohortFemur lengthGrowth outcomesUltrasound measurementsLinear mixed effects modelsBirth cohort
2016
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry
El-Beshlawy A, Tylki-Szymanska A, Vellodi A, Belmatoug N, Grabowski GA, Kolodny EH, Batista JL, Cox GF, Mistry PK. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics And Metabolism 2016, 120: 47-56. PMID: 28040394, DOI: 10.1016/j.ymgme.2016.12.001.Peer-Reviewed Original ResearchConceptsEnzyme replacement therapyInternational Collaborative Gaucher Group Gaucher RegistryGD3 patientsGaucher RegistryPrimary central nervous system involvementImiglucerase enzyme replacement therapyCentral nervous system involvementGaucher diseaseSingle-center seriesGrowth outcomesNervous system involvementGaucher disease type 3Height z-scoreNumber of patientsLife-prolonging benefitsBroad phenotypic spectrumImiglucerase treatmentVisceral diseaseHemoglobin levelsPlatelet countReplacement therapySevere anemiaVisceral manifestationsSpleen volumeSystem involvementGrowth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth
Navarrete CT, Wrage LA, Carlo WA, Walsh MC, Rich W, Gantz MG, Das A, Schibler K, Newman NS, Piazza AJ, Poindexter BB, Shankaran S, Sánchez PJ, Morris BH, Frantz ID, Van Meurs KP, Cotten CM, Ehrenkranz RA, Bell EF, Watterberg KL, Higgins RD, Duara S, Network E, Das A, Gantz M, Jobe A, Caplan M, Fanaroff A, Wilson-Costello D, Siner B, Zadell A, DiFiore J, Bhola M, Friedman H, Yalcinkaya G, Donovan E, Narendran V, Yolton K, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Gratton T, Goldberg R, Goldstein R, Ashley P, Auten K, Fisher K, Foy K, Freedman S, Gustafson K, Lohmeyer M, Malcolm W, Wallace D, Stoll B, Adams-Chapman I, Buchter S, Carlton D, Carter S, Fritz S, Hale E, Hutchinson A, LaRossa M, Smikle G, Archer S, Dusick A, Lemons J, Myers G, Wilson L, Hamer F, Cook A, Herron D, Lytle C, Minnich H, Berberich M, Blaisdell C, Gail D, Kiley J, Poole W, Newman J, Hastings B, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Stevenson D, Hintz S, Ball M, Bentley B, Bruno E, Davis A, DeAnda M, DeBattista A, Huffman L, Kohn J, Proud M, Pyle R, St. John N, Weiss H, Fiascone J, McGowan E, Furey A, MacKinnon B, Nylen E, Brussa A, Sibley C, Ambalavanan N, Peralta-Carcelen M, Collins M, Cosby S, Phillips V, Bailey K, Biasini F, Hopkins M, Johnston K, Krzywanski S, Nelson K, Patterson C, Rector R, Rodriguez L, Soong A, Whitley S, York S, Widness J, Acarregui M, Klein J, Colaizy T, Johnson K, Eastman D, Bauer C, Everett-Thomas R, Calejo M, Diaz A, Eguaras S, Garcia A, Hamlin-Smith K, Berkowits M, Hiriart-Fajardo S, Pierre H, Rigaud A, Stroerger A, Ohls R, Fuller J, Rohr J, Lacy C, Lowe J, Montman R, Brion L, Rosenfeld C, Salhab W, Heyne R, Adams S, Allen J, Chen L, Grau L, Guzman A, Hensley G, Heyne E, Hickman J, Lepps M, Madden L, Miller N, Morgan J, Solis A, Torres L, Boatman C, Vasil D, Kennedy K, Tyson J, Akpa E, Alaniz N, Dieterich S, Evans P, Green C, Harris B, Jiminez M, Lis A, Martin K, Martin S, McDavid G, Morris B, Poundstone M, Reddoch S, Siddiki S, Simmons M, Tate P, Wright S, Sood B, Pappas A, Bara R, Billian E, Goldston L, Johnson M, Bhandari V, Jacobs H, Cervone P, Gettner P, Konstantino M, Poulsen J, Taft J, Butler C, Close N, Gilliam W, Greisman S, Romano E, Williams J. Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth. The Journal Of Pediatrics 2016, 176: 62-68.e4. PMID: 27344218, PMCID: PMC5327617, DOI: 10.1016/j.jpeds.2016.05.070.Peer-Reviewed Original ResearchConceptsWeeks postmenstrual agePostmenstrual agePreterm infantsGrowth failureGrowth outcomesDifferent oxygen saturation targetsOxygen saturation target rangeBetter growth velocityOxygen saturation targetsOxygenation Randomized TrialPoor growth outcomesPostnatal day 7Robust Poisson regressionGrowth velocitySaturation targetsSpO2 targetsRandomized trialsSupplemental oxygenOxygen saturationTreatment groupsAnthropometric measuresDay 7Poisson regressionInfantsDifferent oxygen saturations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply